ARTICLE | Clinical News
Xolair omalizumab humanized monoclonal antibody against IgE regulatory update
March 31, 2003 8:00 AM UTC
The FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) will review on May 15 a BLA for Xolair from DNA, NVS and TNOX. The companies are seeking approval of the anti-IgE antibody to treat moderat...